Michael Kagnoff is a partner in DLA Piper’s Corporate and Finance group, focusing his practice on general corporate representation of established and emerging technology, clean technology, medical device, biotech, and healthcare services companies.

He has extensive experience in public offerings, mergers and acquisitions, venture capital financing, strategic partnerships, and licensing agreements. Mr. Kagnoff has represented some of California’s most prominent venture funds for their investments in portfolio companies.

His clients have included NuVasive, DTS, Adventrx, AMN Healthcare, Nirvanix, Verimatrix, Eyespot, INC Research, Ascent Healthcare Solutions, Reva Medical, Lipothera, Leptos Biomedical, Anaborex and Baronova.

Mr. Kagnoff is listed in the 2005, 2006, and 2007 editions of The Best Lawyers in America.

Допуск к адвокатской практике

• California

Членства

• State Bar of California
• Board of Directors, San Diego Telecom Council